Navigation Links
Georgetown Medical Center collaborates to develop cancer research database
Date:7/29/2008

Washington, DCThe field of personalized cancer research and treatment grows with each day. And a new collaboration with Washington's largest biomedical research organization and an international research and biobanking company is contributing to that growth.

Georgetown University Medical Center announced today an agreement with Indivumed GmbH, based in Hamburg, Germany, which provides the foundation for the analysis of complex clinical molecular signatures from cancer patients, enabling researchers and physicians to better diagnose and tailor cancer treatments for individual patients. This arrangement builds upon a one-year agreement currently in place at Georgetown that established a high-quality tumor biobank and clinical database for pancreatic cancer and which now also includes cancer of the breast and colon.

The expanded collaboration will grow to include a clinical database of prostate, glioblastoma and renal cancer. Together, the institutions will work to establish a robust portfolio of research collaborations, supported by a state-of-the-art biobanking infrastructure and protocol, using Indivumed's established scientific approach, and a multidimensional, integrated clinical and molecular database of cancer.

"Integrating scientific, medical, and technological expertise and assets will transform our ability to analyze complex clinical data relating to specific diseases, employing a more comprehensive, system-level approach to how we treat patients," says Howard J. Federoff, MD, PhD, Executive Vice President for Health Sciences at GUMC. "We're starting with cancer, and hope this kind of research will lead to better, more individually targeted treatments."

The agreement will expand upon the Indivumed Biobank protocol already begun at Georgetown University Hospital, expanding the collection, storage, analysis and utilization of biospecimens. This includes prospective and standardized collection of pre-, intra- and post-surgical patient data and biospecimen data by specially trained research associates, extracting clinical data from existing clinical systems, developing an enhanced collaborative relationship with the MedStar Health system, which owns and operates Georgetown University Hospital through a clinical partnership agreement with the university, and eventually developing partnerships with national health systems to establish a network of biobanking partnerships for specimen collection.

"Indivumed's approach to standardized and high-quality biobanking and data management as a foundation for individualized medical treatment aligns well with GUMC's approach to a database of cancer," says Hartmut Juhl, MD, CEO of Indivumed and former GUMC faculty member.

The collaboration is a key step in the future development of the Georgetown Database of Cancer (G-DOC) at Lombardi Comprehensive Cancer Center at Georgetown. The G-DOC will be designed to marry clinical information from patients in clinical trials with molecular characteristics of their cancer. This effort will define the molecular features that underlie prognosis and responsiveness to therapy in patients, providing a basis for personalized medicine and a tool for target discovery and drug development.

"Georgetownand its Lombardi Comprehensive Cancer Centeris committed to reducing the burden of human cancer through the discovery and early adoption of cutting-edge systems biology-based tools," says Louis M. Weiner, MD, director, Lombardi Comprehensive Cancer Center. Lombardi is one of only 41 comprehensive cancer centers in the country and the only one in the Washington area. "Collaborating with a company with an established, successful research strategy such as Indivumed brings together the strengths of both institutions in order to achieve this goal."


'/>"/>

Contact: Laura Cavender
lsc6@georgetown.edu
202-687-5100
Georgetown University Medical Center
Source:Eurekalert

Related medicine news :

1. No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones
2. Georgetown researchers find stem cell marker controls 2 key cancer pathways
3. Georgetown U student selected for prestigious Bouchet Society
4. Georgetown leads major effort to combat disparities in DC stroke care
5. New USAID grant helps Georgetown meet unmet family planning needs worldwide
6. Southern Home Medicals Encore Medical Staffing Division Poised to Benefit from Major Growth in Nursing Industry
7. InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution
8. Partnership Improves Medical Records Management within Corrections Facilities
9. Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008
10. New $4.2m UQ medical center to boost rural doctor numbers
11. Connecticut State Medical Society Chooses gloStream as a Preferred Electronic Medical Record and Practice Management Solutions Provider
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ... "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, and ... maintaining fulfilling lives. “We are prolonging life 6 years in the last 3 ...
(Date:12/2/2016)... ... 2016 , ... The PAINWeekEnd Regional Conference will be hosted ... Honolulu, offering local frontline clinicians the opportunity to extend their certified continuing medical ... supplemental training related to pain management has surged dramatically in recent years, with ...
(Date:12/2/2016)... ... , ... Sourced from the Isbre Springs beneath the 5,000 year old Hardanger ... of just 6 ppm TDS (Total Dissolved Solids) in addition to its excellent taste ... several ShopRite and FoodTown stores in NJ and received rave comments from consumers. , ...
(Date:12/2/2016)... ... December 02, 2016 , ... Yisrayl Hawkins, at The House ... this current generation fits into Bible Prophecy. Yisrayl says this generation, known as the ... this conclusion, showing how the details line up exactly with Bible Prophecy – a ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... announced today that it has raised $6.0 million in an initial round of ... Health’s conviction that patients and their caregivers can receive far better care through ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016  The Addiction Treatment Advisory ... of Managed Care Pharmacy (AMCP), has released detailed ... address the opioid addiction crisis, including through improved ... ATAG,s newly released paper, "The Role ... Naloxone," addresses many issues around gaps and barriers ...
(Date:12/2/2016)... 2016 CVS Health Corporation (NYSE: ... York City on Thursday, December 15, 2016, beginning at 8:00 a.m. (ET). ... provide an in-depth review of the company,s strategies to ... will also discuss 2017 earnings guidance during the event. ... event will be broadcast simultaneously on the Investor Relations ...
(Date:12/2/2016)... 2, 2016   CytoSorbents Corporation (NASDAQ: ... European Union approved CytoSorb ® cytokine adsorber to ... worldwide, announced that Dr. Phillip Chan , Chief ... LD Micro Main Event investor conference held from ... Luxe Sunset Boulevard Hotel in Los Angeles, ...
Breaking Medicine Technology: